I reported previously (see here) on the brain analysis system developed by Israel’s elminda. The EU has just awarded elminda a 2-year grant through its Horizon 2020’s phase 2 program. It will help elminda develop and trial its BNA-PREDICT product for depression.

https://elminda.com/multi-million-euro-award-european-commission-will-support-deployment-elmindas-bna-predict-improve-depression-treatment-effectiveness/